Health

Zhongchao Inc. Announces Pricing of $12 Million Firm Commitment Initial Public Offering

BEIJING, Feb. 22, 2020 /PRNewswire/ -- Zhongchao Inc. ("Zhongchao" or the "Company") (NASDAQ:ZCMD), a provider of healthcare information, professional training and educational services to healthcare professionals and the public in China, today announced the pricing of its initial public offering o...

2020-02-22 10:21 243

Coronavirus: International Concern Growing Over Healthcare Workers' Wellbeing

MIAMI, Feb. 22, 2020 /PRNewswire/ --?As concern over potential transmission of the Coronavirus to healthcare workers treating afflicted patients continues to rise, industry expert Radiation Shield Technologies is issuing a call-to-action to ensure healthcare workers have access to the necessary p...

2020-02-22 07:15 370

Enterprises Resume Work and Production in Xi'an, China amid Novel Coronavirus Outbreak

XI'AN, China, Feb. 21, 2020 /PRNewswire/ -- As China continues to tackle the?n ovel coronavirus outbreak, its industries have started to return to work in an orderly manner.Xi'an, one of the national central cities and an important scientific research, educational and industrial base inChina, has ...

2020-02-21 19:36 428

Foreign-funded companies in Changzhou National Hi-Tech District join battle against COVID-19

CHANGZHOU, China, Feb. 21, 2020 /PRNewswire/ -- A growing number of the foreign-funded firms located in Changzhou?National?Hi-Tech?District have joined in the efforts to control and prevent the further spread of the novel coronavirus (COVID-19).?ThyssenKrupp?Steering?System (Changzhou)?CEO Sebas...

2020-02-21 16:32 562

Zoomlion Takes Steps to Combat the Novel Coronavirus (Covid-2019) Outbreak

CHANGSHA, China, Feb. 21, 2020 /PRNewswire/ -- Following the outbreak of Covid-19 novel coronavirus, Zoomlion Heavy Industry Science and Technology Co, (01157.HK) - a leading Chinese maker of engineering and agricultural equipment - immediately setup a Prevention and Control Team led by President...

2020-02-21 15:36 1312

Nearly VND 20 billion sponsored by Vingroup for research projects on response to novel coronavirus

HANOI, Vietnam, Feb. 21, 2020 /PRNewswire/ -- 3 units funded by Vingroup Innovation Foundation (VINIF) include The Company for Vaccine and Biological Production No.1 (Vabiotech), Pasteur Institute inHo Chi Minh City and Institute of Preventive Medicine and Public Health.

2020-02-21 10:09 609

Yum China Stands with Communities to Fight Coronavirus

SHANGHAI, Feb. 20, 2020 /PRNewswire/ -- Yum China Holdings, Inc. (the "Company" or "Yum China") (NYSE: YUMC) today announced that it has been actively mobilizing resources in a multi-pronged response to the outbreak of novel coronavirus (COVID-19). As part of its efforts, the Company immediately ...

2020-02-21 09:54 1312

S-CELL Becomes the First in Asia to Introduce Consumer Epigenetics Testing and is the Most Advanced Test in the World

HONG KONG, Feb. 21, 2020 /PRNewswire/ -- S-CELL, in partnership with Chronomics, is the first company inAsia to introduce Healthspan, the most advanced epigenetic testing service in the world. Chronomics was established in 2017 and later officially launched the epigenetics testing kit in hopes to...

2020-02-21 09:20 664

VolitionRx Limited Announces Full Fiscal Year 2019 Financial Results and Business Update

AUSTIN, Texas, Feb.?20, 2020 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced financial results and a business update for the full fiscal year endedDecember 31, 2019. Volition management will host a conference call tomorrow,February 21, at 8:30 a.m. U.S. Easte...

2020-02-21 05:10 1426

StoneWise AI-driven Drug Discovery Platform: Investigation and Repurpose of Nucleoside-based RNA Polymerase Inhibitors and Their Potential Use in COVID-19 Infection Treatment

BEIJING, Feb. 20, 2020 /PRNewswire/ -- In a campaign to screen drugs for the treatment of COVID-19, the disease caused by SARS-CoV-2, StoneWise, a company specialized in applying artificial intelligence to innovative drug design solutions for innovative drug R&D enterprises and institutions, has ...

2020-02-20 20:04 307

Hyatt Regency Danang Resort and Spa Implemented Precautionary COVID-19 Measures

DA NANG, Vitenam, Feb. 20, 2020 /PRNewswire/ -- The safety and wellbeing of?the guests and colleagues is a top priority.?Hyatt hotels globally, including Hyatt Regency Danang Resort and Spa, have already implemented precautious measures in response to coronavirus concerns, including colleague edu...

2020-02-20 19:15 746

Sihuan Pharmaceutical Announces Acquisition of All Interests and Intellectual Property Rights of Plazomicin, A New Generation of Aminoglycoside Antibiotics in the Greater China Region

HONG KONG, Feb. 20, 2020 /PRNewswire/ -- Sihuan Pharmaceutical Holdings Group Ltd. (HKEX: 0460, "Sihuan Pharmaceutical" or the "Company", together with its subsidiaries, the "Group") is pleased to announce that Xuanzhu (HK) Biopharmaceutical Limited (''Xuanzhu''), a wholly-owned subsidiary of the...

2020-02-20 18:59 2192

111 to Announce Fourth Quarter and Fiscal Year 2019 Unaudited Financial Results on March 12, 2020

SHANGHAI, Feb. 20, 2020 /PRNewswire/ --?111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform inChina , today announced that it will report its unaudited financial results for the fourth quarter and fiscal year 2019 endedDecember 31, 2019, bef...

2020-02-20 17:15 1662

111 Partners with Financial Institutions in Battle Against Coronavirus

SHANGHAI, Feb. 20, 2020 /PRNewswire/ -- 111, Inc. (NASDAQ: YI, "111" or the "Company") has announced that it will leverage its knowhow and technology in the battle against the novel coronavirus (COVID-19) public health crisis, through partnerships with some ofChina's leading financial institution...

2020-02-20 17:00 1700

Ten billion investment to build Chengdu medical city to create a new highland for the international health industry

CHENGDU, China, Feb. 20, 2020 /PRNewswire/ -- In 2019, with the continuous advancement of "three medical integration", Chengdu Medical City's three medical innovation center, as "Western China Biomedical Innovation Center", submitted a satisfactory answer sheet: 58 new contracted projects (47 thr...

2020-02-20 16:04 257

Hummingbird Bioscience Announces Agreement with Mycenax Biotech for Production of Anti-VISTA Antibody HMBD-002 for Cancer Clinical Trial

HOUSTON, Feb. 20, 2020 /PRNewswire/ -- Hummingbird Bioscience, an innovative biotherapeutics company pioneering the discovery of new breakthrough antibody therapeutics for difficult-to-treat conditions, today announced it has signed an agreement with Mycenax Biotech for the production of material...

2020-02-20 15:15 684

Industrial enterprises in Weifang, Shandong resume work and production while fighting epidemic

WEIFANG, China, Feb. 20, 2020 /PRNewswire/ -- In order to respond to the epidemic of novel coronavirus pneumonia (NCP), the government ofShandong Province has issued a notice that requires enterprises that are key to national economy and people's livelihoods to immediately resume work and product...

2020-02-20 13:37 259

Infinitus releases 2019 Corporate Social Responsibility Report promoting a healthy lifestyle

GUANGZHOU, China, Feb.20, 2020 /PRNewswire/ -- The general public has come to see the taking of social responsibility as a basic requirement of all companies. On February 20,?Infinitus (China) Company Ltd released its 2019 Corporate Social Responsibility Report on its online platform. Given th...

2020-02-20 10:00 756

InDex Pharmaceuticals' In-depth Analysis of the CONDUCT Study Confirms the Successful Top Line Results and Supports the Strategy Going Forward

STOCKHOLM, Feb. 20, 2020 /PRNewswire/ -- InDex Pharmaceuticals Holding AB (publ) today announced the conclusions from in-depth analysis of the complete data set from the phase IIb dose optimisation study CONDUCT, evaluating the first-in-class TLR9 agonist cobitolimod for the treatment of moderate...

2020-02-20 06:00 783

Nimble Announces Collaboration with Genentech to Discover and Develop Novel Peptide-Based Therapeutics

MADISON, Wisconsin, Feb. 20, 2020 /PRNewswire/ --?Nimble Therapeutics, Inc. today announced a multi-year collaboration with Genentech, a member of the Roche Group, to accelerate discovery and development of novel peptide-based medicines for targets across a range of diseases. The collaboration w...

2020-02-20 01:00 877
12345 ... 800